Medpace stock 'faces downside risk' amid biotech funding struggles, says Jefferies

Sep 25, 2024 - 16:00
Medpace stock 'faces downside risk' amid biotech funding struggles, says Jefferies

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow